Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 17, 2002
Set theory in diagnostic reasoning
Rui-Bao Tang, Qin-Fang Deng, Hou-Qi Liu
Respirology (Carlton, Vic.)
|
April 9, 2009
Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer
Qin-Fang Deng, Cai-Cun Zhou, Chun-Xia Su
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 29, 2009
[Sensitivity of two cell lines with acquired resistance to gefitinib to several chemotherapeutic drugs]
Qin-fang Deng, Bo Su, Yin-min Zhao, et al.
Journal of Cancer
|
April 15, 2020
Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis
Qin-Fang Deng, Qi-Yu Fang, Xian-Xiu Ji, et al.
Journal of Public Health Medicine
|
October 25, 2003
A preliminary study on the relation between thunderstorms and mortality of in-patients
Qin-fang Deng, Cai-cun Zhou, Jian-fong Xu, et al.
Biochemical and Biophysical Research Communications
|
March 16, 2017
Corrigendum to "SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth" [Biochem. Biophys. Res. Commun. 483 (2017) 880-884]
Jie Luo, Yu-Chen Bao, Xian-Xiu Ji, et al.
Oncology Letters
|
February 13, 2016
Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway
Qin-Fang Deng, B O Su, Yin-Min Zhao, et al.
Biochemical and Biophysical Research Communications
|
January 12, 2017
SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth
Jie Luo, Yu-Chen Bao, Xian-Xiu Ji, et al.
The Clinical Respiratory Journal
|
July 16, 2019
Comparison among different presentations of venous thromboembolism because of lung cancer
Jian Guo, Qin-Fang Deng, Wei Xiong, et al.
American Journal of Cancer Research
|
September 11, 2023
DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer
Qin-Fang Deng, Chao Li, Jing Liu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 17, 2002
Set theory in diagnostic reasoning
Rui-Bao Tang, Qin-Fang Deng, Hou-Qi Liu
Respirology (Carlton, Vic.)
|
April 9, 2009
Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer
Qin-Fang Deng, Cai-Cun Zhou, Chun-Xia Su
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 29, 2009
[Sensitivity of two cell lines with acquired resistance to gefitinib to several chemotherapeutic drugs]
Qin-fang Deng, Bo Su, Yin-min Zhao, et al.
Journal of Cancer
|
April 15, 2020
Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis
Qin-Fang Deng, Qi-Yu Fang, Xian-Xiu Ji, et al.
Journal of Public Health Medicine
|
October 25, 2003
A preliminary study on the relation between thunderstorms and mortality of in-patients
Qin-fang Deng, Cai-cun Zhou, Jian-fong Xu, et al.
Biochemical and Biophysical Research Communications
|
March 16, 2017
Corrigendum to "SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth" [Biochem. Biophys. Res. Commun. 483 (2017) 880-884]
Jie Luo, Yu-Chen Bao, Xian-Xiu Ji, et al.
Oncology Letters
|
February 13, 2016
Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway
Qin-Fang Deng, B O Su, Yin-Min Zhao, et al.
Biochemical and Biophysical Research Communications
|
January 12, 2017
SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth
Jie Luo, Yu-Chen Bao, Xian-Xiu Ji, et al.
The Clinical Respiratory Journal
|
July 16, 2019
Comparison among different presentations of venous thromboembolism because of lung cancer
Jian Guo, Qin-Fang Deng, Wei Xiong, et al.
American Journal of Cancer Research
|
September 11, 2023
DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer
Qin-Fang Deng, Chao Li, Jing Liu, et al.
Page
of 1